News, Politics, Research

FDA Expands Epidiolex Access for Those with Tuberous Sclerosis Complex

September 16, 2020 02:42 pm ET Estimated Read Time: 4 Minutes

FDA Expands Epidiolex Access for Those with Tuberous Sclerosis Complex

Though cannabis is becoming increasingly legal across the nation, both for recreational and medical purposes, there’s no sign that the US government intends to legalize cannabis on the federal level. This causes complications as more people than ever before are exploring cannabis for medical purposes. The lack of federal legalization limits the way federally funded organizations are able to interact with cannabis. It curtails the amounts and types of research that are able to be done, placing unfortunate limitations on how much we can learn about the uses of cannabis—and without extensive research, of course, it’s that much more difficult to fight for federal legalization.

A lack of federal legalization also makes it more difficult for the Food and Drug Administration (FDA) to approve cannabis-based products. Whether for medical or recreational purposes, most of the cannabis products we are currently able to procure have not been FDA approved yet. To date, the organization has no application for approval of any cannabis-based medical product.

However, there is one notable example—Epidiolex. And recently, the FDA has added to its accepted use of the drug.

What is Epidiolex?

Epidiolex is the sole cannabis-derived pharmaceutical that has been approved by the FDA – although it is worth noting that the organization has also approved three synthetic cannabis-related products. Epidiolex has a complex history. It was approved in 2018 as a Schedule V substance, which is to say, a substance with a low potential for abuse considered not to be dangerous. However, Epidiolex contains CBD. Up until March 2020, CBD was lumped in with cannabis as a Schedule I substance—highly addictive and with no accepted medical uses.

Epidiolex was approved specifically for treating patients suffering from seizures associated with Dravet Syndrome, which is a severe form of epilepsy that affects between 20,000 and 40,000 people worldwide. Though Dravet Syndrome typically manifests itself in the first year of life, Epidiolex is only approved for treating patients two years of age and older.

Of course, it’s wonderful to see the FDA approve this substance to help those suffering from this rare condition. But we know that cannabis is effective at helping to manage seizures caused by other forms of epilepsy—as well as other medical conditions—also. So why limit the use of Epidiolex to just this one condition?

The FDA Adds a New Condition for Treatment

It seems the FDA has been thinking along these same lines.

Just this year, Epidiolex was approved for the treatment of Tuberous Sclerosis Complex, a condition characterized by the growth of benign tumors throughout the body. Though these tumors are noncancerous in nature, their presence can cause health problems, including epilepsy. Tuberous sclerosis complex affects about a million people worldwide. About 85% of these patients experience epilepsy as an effect of the condition, and more than half are unable to achieve seizure control.

However, trial results have shown a positive impact when patients were treated with Epidiolex, and doctors are pleased to add this new option to their list of potential tools for helping their patients, Epidiolex could make a difference in the lives of people suffering from tuberous sclerosis complex, and that’s a huge step for the FDA to take.

It also represents forward motion in the way we deal with cannabis in this country. Though the lack of federal legalization can be frustrating and difficult, and though it is holding us back, it is always encouraging to see organizations like the FDA make movements in the right direction. Soon, we hope to see cannabis-based treatment options made available for people managing a much wider variety of health conditions.

Author, Share & Comments

Posted by Kat Helgeson

Kat Helgeson comes from a ten year career in social media marketing and content creation. She takes pride in her ability to communicate the culture and values of an organization via the written word. Kat is also the author of numerous books for young adults. Her titles have received the Junior Library Guild Award, the Bank Street College of Education Best Books of the Year Distinction, and been featured on the Illinois Reads selection list. Her work has been translated into Dutch and German.

Post Your Comments

What is Epidiolex?
See If You Qualify For Medical Marijuana - Select Your State!
The FDA Adds a New Condition for Treatment

Do you qualify for an MMJ card?

Medical vs. Recreational Cannabis Taxes Explained

Currently, 24 states sell cannabis recreationally. If you are in one of these states, it’s understandable that you might feel tempted to forget about the medical card process. Even if you qualify as a patient, it’s an application process that does take some information and patience. While recreational cannabis is available in many states, there…

By Sarah Welk Baynum April 28, 2025

Cannabis Trichomes: The Key to Potency and Quality

What gives cannabis its powerful effects, rich aroma, and frosty appearance? The answer lies in crystal-like structures called trichomes that cover the surface of cannabis flowers. This is where the cannabis cultivation magic happens because they produce and store the majority of compounds responsible for the plant’s potency, flavor, and therapeutic benefits. Trichomes are the…

By Hannah Vysoky April 29, 2025

A Medical Cannabis Tincture: How To Make Green Dragon Tincture

If pain is an aspect of your cannabis journey, you might be interested in a Green Dragon tincture. This homemade creation will not turn you into a magic dragon, but it could make you feel on top of the world if you are dealing with chronic pain. Pain can slow us down. When the body…

By Sarah Welk Baynum April 24, 2025

The Long and Short-Term Effects of Marijuana on Speech and Social Settings

Cannabis is known for its significant effect on the human brain—which is what makes it so beneficial for helping people with mental health conditions. However, the portion of the brain responsible for speech can also be affected. After consuming cannabis, some people may experience acute, subtle speech deviations or difficulties, primarily in maintaining the logical…

By Hannah Vysoky April 22, 2025

All the Jazz Regarding Chazzed Bangers and How to Avoid Them

There is a lot to learn when it comes to the world of cannabis concentrates. In particular, proper banger health is essential for any dab rig. The devices used to smoke concentrates are not called a bowl, but one of the most popular forms of consumption seems to be using a dab rig. Dab rigs…